Acquired antibiotic resistance genes: An overview

Frontiers in Microbiology

Volumn 2, Issue SEP, 2011, Pages

  Van Hoek, Angela H A M ^a   Mevius, Dik ^b,c   Guerra, Beatriz ^d   Mullany, Peter ^e   Roberts, Adam Paul ^e   Aarts, Henk J M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c UTRECHT UNIVERSITY   (Netherlands)

^d FEDERAL INSTITUTE FOR RISK ASSESSMENT   (Germany)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Acquired; Antibiotics; Antimicrobial resistance mechanisms; Mobile genetic elements

Indexed keywords

BACTERIA (MICROORGANISMS);

EID: 84861998997     PISSN: None     EISSN: 1664302X     Source Type: Journal    
DOI: 10.3389/fmicb.2011.00203     Document Type: Review

References (185)

1. Aarestrup, F. M. (1995). Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms. Microb. Drug Resist. 1, 255-257.
2. Aarestrup, F. M., and Jensen, N. E. (1998). Development of penicillin resistance among Staphylococcus aureus isolated from bovine mastitis in Denmark and other countries. Microb. Drug Resist. 4, 247-256.
3. Abraham,E. P.,and Chain,E. (1940). An enzyme from bacteria able to destroy penicillin. Nature 146, 837.
4. Ackermann, G., and Rodloff, A. C. (2003). Drugs of the 21st century: telithromycin (HMR 3647) the first ketolide. J. Antimicrob. Chemother. 51, 497-511.
5. Adrian, P. V., Thomson, C. J., Klugman, K. P., and Amyes, S. G. B. (2000). New gene cassettes for trimethoprim resistance, dfr13, and streptomycinspectinomycin resistance, aadA4, inserted on a class 1 integron. Antimicrob. Agents Chemother. 44, 355-361.
6. Allen, H. K., Donato, J., Wang, H. H., Cloud-Hansen, K. A., Davies, J., and Handelsman, J. (2010). Call of the wild: antibiotic resistance genes in natural environments. Nat. Rev. Microbiol. 8, 251-259.
7. Ambler, R. P. (1980). The structure of β-lactamases. Philos. Trans. R. Soc. Lond. B Biol. Sci. 289, 321-331.
8. Amyes,S. G. B.,and Towner,K. J. (1990). Trimethoprim resistance; epidemiology and molecular aspects. J. Med. Microbiol. 31, 1-19.
9. Andes, D. R., and Craig, W. A. (2005). "Cephalosporins," in Principles and Practice of Infectious Diseases, eds G. L. Mandell, J. E. Bennett, and R. Dolin (Philadelphia, PA: Churchill Livingstone), 294-311.
10. Aune, T. E. V., and Aachmann, F. L. (2010). Methodologies to increase the transformation efficiencies and the range of bacteria that can be transformed. Appl. Microbiol. Biotechnol. 85, 1301-1313.
11. Begg, E. J., and Barclay, M. L. (1995). Aminoglycosides 50 years on. Br. J. Clin. Pharmacol. 39, 597-603.
12. Bissonnette, L., Champetier, S., Buisson, J.-P., and Roy, P. H. (1991). Characterization of the non-enzymatic chloramphenicol resistance (cmlA) gene of the In4 integron of Tn1696: similarity of the product to transmembrane transport proteins. J. Bacteriol. 173, 4493-4502.
13. Bradford, P. A. (2001). Extendedspectrum β-lactamase in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin. Microbiol. Rev. 14, 933-951.
14. Briggs, C. E., and Fratamico, P. M. (1999). Molecular characterization of an antibiotic resistance gene cluster of Salmonella typhimurium DT104. Antimicrob. Agents Chemother. 43, 846-849.
15. Brown, M. G., Mitchell, E. H., and Balkwill, D. L. (2008). Tet 42, a novel tetracycline resistance determinant isolated from deep terrestrial subsurface bacteria. Antimicrob. Agents Chemother. 52, 4518-4521.
16. Burton, B., and Dubnau, D. (2010). Membrane-associated DNA transport machines. Cold Spring Harb. Perspect. Biol. 2, a000406.
17. Bush, K. (1988). β-Lactamase inhibitors from laboratory to clinic. Clin. Microbiol. Rev. 1, 109-123.
18. Bush, K. (1989). Characterization of β-lactamases. Antimicrob. Agents Chemother. 33, 259-263.
19. Bush, K., and Jacoby, G. A. (2010). Updated functional classification of β-lactamases. Antimicrob. Agents Chemother. 54, 969-976.
20. Bush, K., Jacoby, G. A., and Medeiros, A. A. (1995). A functional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob. Agents Chemother. 39, 1211-1233.
21. Cantón, R., and Coque, T. M. (2006). The CTX-M beta-lactamase pandemic. Curr. Opin. Microbiol. 9, 466-475.
22. Cantón, R., Novais, A., Valverde, A., Machado, E., Peixe, L., Baquero, F., and Coque, T. M. (2008). Prevalence and spread of extended-spectrum βlactamase-producing Enterobacteriaceae in Europe. Clin. Microbiol. Infect. 14, 144-153.
23. Carattoli,A. (2001). Importance of integrons in the diffusion of resistance. Vet. Res. 32, 243-259.
24. Carattoli, A. (2003). Plasmid-mediated antimicrobial resistance in Salmonella enterica. Curr. Issues Mol. Biol. 5, 113-122.
25. Carattoli, A. (2009). Resistance plasmid families in Enterobactericeae. Antimicrob. Agents Chemother. 53, 2227-2238.
26. Casadewall,B.,and Courvalin,P. (1999). Characterization of the vanD glycopeptide resistance gene cluster from Enterococcus faecium BM4339. J. Bacteriol. 181, 3644-3648.
27. Cattoir, V., and Nordmann, P. (2009). Plasmid-mediated quinolone resistance in gram-negative bacterial species: an update. Curr. Med. Chem. 16, 1028-1046.
28. Cattoir, V., Poirel, L., and Nordmann, P. (2008). Plasmid-mediated quinolone resistance pump QepA2 in an Escherichia coli isolate from France. Antimicrob. Agents Chemother. 52, 3801-3804.
29. Cavaco, L. M., Hasman, H., Xia, S., and Aarestrup, F. M. (2009). qnrD, a novel gene conferring transferable quinolone resistance in Salmonella enterica serovar Kentucky and Bovismorbificans strains of human origin. Antimicrob. Agents Chemother. 53, 603-608.
30. Chaconas, G., and Kobryn, K. (2010). Structure,function,and evolution of linear replicons in Borrelia. Annu. Rev. Microbiol. 64, 185-202.
31. Chambers, S. P., Prior, S. E., Barstow, D. A., and Minton, N. P. (1988). The pMTL niccloning vectors. I. Improved pUC polylinker regions to facilitate the use of sonicated DNA for nucleotide sequencing. Gene 68, 139-149.
32. Chopra, I. (1994). Tetracycline analogs whose primary target is not the bacterial ribosome. Antimicrob. Agents Chemother. 38, 637-640.
33. Chopra, I., Hawkey, P. M., and Hinton, M. (1992). Tetracyclines, molecular and clinical aspects. J. Antimicrob. Chemother. 29, 245-277.
34. Chopra, I., and Roberts, M. C. (2001). Tetracycline antibiotics: mode of action, applications, molecular biology and epidemiology of bacterial resistance. Microbiol. Mol. Biol. Rev. 65, 232-260.
35. Cookson, A. L., Noel, S., Hussein, H., Perry, R., Sang, C., Moon, C. D., Leahy, S. C., Altermann, E., Kelly, W. J., and Attwood, G. T. (2011). Transposition of Tn916 in the four replicons of the Butyrivibrio proteoclasticus B316T genome. FEMS Microbiol. Lett. 316, 144-151.
36. Courvalin, P. (1990). Plasmid-mediated 4-quinolone resistance: real or apparent absence? Antimicrob. Agents Chemother. 34, 681-684.
37. Courvalin, P. (2008). New plasmidmediated resistances to antimicrobial agents. Arch. Microbiol. 189, 289-291.
38. Couturier, M., Bex, F., Bergquist, P. L., and Maas, W. K. (1988). Identification and classification of bacterial plasmids. Microbiol. Rev. 52, 375-395.
39. Datta, N., and Kontomichalou, P. (1965). Penicillinase synthesis controlled by infectious R factors in enterobacteriaceae. Nature 208, 239-241.
40. Davies, J. (1994). Inactivation of antibiotics and the dissemination of resistance genes. Science 64, 375-382.
41. Davies, J., and Wright, G. D. (1997). Bacterial resistance to aminoglycoside antibiotics. Trends Microbiol. 5, 234-240.
42. Del Grosso, M., Camilli, R., Barbabella, G., Blackman Northwood, J., Farrell, D. J., and Pantosti, A. (2011). Genetic resistance elements carrying mef subclasses other than mef(A) in Streptococcus pyogenes. Antimicrob. Agents Chemother. 55, 3226-3230.
43. Depardieu, F., Podglajen, I., Leclercq, R., Collatz, E., and Courvalin, P. (2007). Modes and modulations of antibiotic resistance gene expression. Clin. Microbiol. Rev. 20, 79-114.
44. Diekema, D. J., and Jones, R. N. (2000). Oxazolidinones: a review. Drugs 59, 7-16.
45. Doi, Y., and Arakawa, Y. (2007). 16S ribosomal RNA methylation: emerging resistance mechanism against aminoglycosides. Clin. Infect. Dis. 45, 88-94.
46. Doi, Y., Wachino, J.-I., and Arakawa, Y. (2008). Nomenclature of plasmidmediated 16S rRNA methylases responsible for panaminoglycoside resistance. Antimicrob. Agents Chemother. 52, 2287-2288.
47. Domagk, G. J. (1935). Ein beitrag zur chemotherapie der bakteriellen infektionen. Dtsch. Med. Wochenschr. 61, 250-253.
48. Drawz, S. M., and Bonomo, R. A. (2010). Three decades of βlactamase inhibitors. Clin. Microbiol. Rev. 23, 160-201.
49. Ehrlich, J., Bartz, Q. R., Smith, R. M., Joslyn, D. A., and Burkholder, P. R. (1947). Chloromycetin a new antibiotic from a soil actinomycete. Science 106, 417.
50. Elbourne, L. D. H., and Hall, R. M. (2006). Gene cassette encoding a3-N -aminoglycoside acetyltransferase in a chromosomal integron. Antimicrob. Agents Chemother. 50, 2270-2271.
51. Fleming, M. P., Datta, N., and Grüneberg, R. N. (1972). Trimethoprim resistance determined by R factors. Br.Med.J.1, 726-728.
52. Flemming, A. (1929). Classics in infectous diseases: on the antibacterial action of cultures of a penicillium, with special reference to their use in the isolation of B. influenzae. Brit. J. Exp. Pathol. 10, 226-236.
53. Fluit, A. C., and Schmitz, F. J. (1999). Class 1 integrons, gene cassettes, mobility, and epidemiology. Eur. J. Clin. Microbiol. Infect. Dis. 18, 761-770.
54. Frost, L. S., and Koraimann, G. (2010). Regulation of bacterial conjugation: balancing opportunity with adversity. Future Microbiol. 5, 1057-1071
55. Galimand, M., Courvalin, P., and Lambert, T. (2003). Plasmid-mediated high level resistance to aminoglycosides in Enterobacteriaceae due to 16S rRNA methylation. Antimicrob. Agents Chemother. 47, 2565-2571.
56. Galimand, M., Sabtcheva, S., Courvalin, P., and Lambert, T. (2005). Worldwide disseminated armA aminoglycoside resistance methylase gene is borne by composite transposon Tn1548. Antimicrob. Agents Chemother. 49, 2949-2953.
57. Gao, Y. (2002). Glycopeptide antibiotics and development of inhibitors to overcome vancomycin resistance. Nat. Prod. Rep. 19, 100-107.
58. Goossens, H. (2009). Antibiotic consumption and link to resistance. Clin. Microbiol. Infect. 15, 12-15.
59. Grape, M. (2006). Molecular Basis for Trimethoprim and Sulphonamide Resistance in Gram Negative Pathogens. Ph.D. thesis, Karolinska Institutet, Stockholm.
60. Hall, R. M., and Collis, C. M. (1995). Mobile gene cassettes and integrons: capture and spread of genes by sitespecific recombination. Mol. Microbiol. 15, 593-600.
61. Hall, R. M., and Stokes, H. W. (1993). Integrons: novel DNA elements which capture genes by sitespecific recombination. Genetica 90, 115-132.
62. Hancock, R. E. W. (1981). Aminoglycoside uptake and mode of actionwith special reference to streptomycin and gentamicin. J. Antimicrob. Chemother. 8, 249-276.
63. Hooper, D. C. (1995). Quinolone mode of action. Drugs 49, 10-15.
64. Hooper, D. C. (2000). Mechanisms of action and resistance of older and newer fluoroquinolones. Clin. Infect. Dis. 31, S24-S28.
65. Howell, E. E. (2005). Searching sequence space: two different approaches to dihydrofolate reductase catalysis. Chembiochem 6, 590-600.
66. Hunter, I. S., and Hill, R. A. (1997). "Tetracyclines, chemistry and molecular genetics of their formation," in Biotechnology of Antibiotics (Drugs and the Pharmaceutical Sciences), ed.W.R.Strohl (London, UK: Informa HealthCare), 659-682.
67. Huovinen, P. (1987). Trimethoprim resistance. Antimicrob. Agents Chemother. 31, 1451-1456.
68. Huovinen, P., Sundström, L., Sewdberg, G., and Sköld, O. (1995). Trimethoprim and sulfonamide resistance. Antimicrob. Agents Chemother. 39, 279-289.
69. Huovinen, P., and Toivanen, P. (1980). Trimethoprim resistance in Finland after five years use of plain trimethoprim. Br.Med.J.280, 72-74.
70. Jacoby, G., Cattoir, V., Hooper, D., Martínez-Martínez, L., Nordmann, P., Pascual, A., Poirel, L., and Wang, M. (2008). qnr Gene nomenclature. Antimicrob. Agents Chemother. 52, 2297-2299.
71. Jacoby, G. A. (2005). Mechanisms of resistance to quinolones. Clin. Infect. Dis. 41, S120-S126.
72. Jacoby, G. A. (2009). AmpC βlactamases. Clin. Microbiol. Rev. 22, 161-182.
73. Jacoby, G. A., and Munoz-Price, L. S. (2005). The new β-lactamases. N. Engl.J.Med.352, 380-391.
74. Jevons, M. P., Coe, A. W., and Parker, M. T. (1963). Methicillin resistance in staphylococci. Lancet 281, 904-907
75. Johnson, A. P., Uttley, A. H. C., Woodford, N., and George, R. C. (1990). Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin. Microbiol. Rev. 3, 280-291.
76. Kadlec, K., and Schwarz, S. (2009). Identification of a novel trimethoprim resistance gene, dfrK, in a methicillin-resistant Staphylococcus aureus ST398 strain and its physical linkage to the tetracycline resistance gene tet(L). Antimicrob. Agents Chemother. 53, 776-778.
77. Keeratipibul, S., Sugiyama, M., and Nomi, R. (1983). Mechanism of resistance to streptothricin of a producing microorganism. Biotechnol. Lett. 5, 441-446.
78. King, D. E., Malone, R., and Lilley, S. H. (2000). New classification and update on the quinolone antibiotics. Am. Fam. Physician 61, 2741-2748
79. Kirst, H. A. (2002). "Introduction to the macrolide antibiotics," in Macrolide Antibiotics, eds W. Schönfeld and H. A. Kirst (Basel: Birkhäuser Verlag), 1-14.
80. Klare, I., Heier, H., Claus, H., Reissbrodt, R., and Witte, W. (1995). vanA-mediated high-level glycopeptide resistance in Enterococcus faecium from animal husbandry. FEMS Microbiol. Lett. 125, 165-171.
81. Klare, I., Konstabel, C., Badstübner, D., Werner, G., and Witte, W. (2003). Occurrence and spread of antibiotic resistances in Enterococcus faecium. Int. J. Food Microbiol. 88, 269-290.
82. Kotra, L. P., Haddad, J., and Mobashery, S. (2000). Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance. Antimicrob. Agents Chemother. 44, 3249-3256.
83. Kotra, L. P., and Mobashery, S. (1998). β-Lactam antibiotics, β-lactamases and bacterial resistance. Bull. Inst. Pasteur 96, 139-150.
84. Kovács, A. T., Smits, W. K., Mironczuk, A. M., and Kuipers, O. P. (2009). Ubiquitous late competence genes in Bacillus species indicate the presence of functional DNA uptake machineries. Environ. Microbiol. 11, 1911-1922.
85. Leclercq, R., Derlot, E., Duval, J., and Courvalin, P. (1988). Plasmid mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N.Engl.J.Med.319, 157-161.
86. Lescher, G. Y., Froelich, E. J., Gruett, M. D., Bailey, J. H., and Brundage, R. P. (1962). 1,8-Naphthyridine derivatives: a new class of chemotherapy agents. J. Med. Pharm. Chem. 5, 1063-1068.
87. Levings, R. S., Lightfoot, D., Elbourne, L. D. H., Djordjevic, S. P., and Hall, R. M. (2006). New integronassociated gene cassette encoding a trimethoprim-resistant DfrB-type dihydrofolate reductase. Antimicrob. Agents Chemother. 50, 2863-2865.
88. Levy, S. B., McMurry, L. M., Barbosa, T. M., Burdett, V., Courvalin, P., Hillen, W., Roberts, M. C., Rood, J. I., and Taylor, D. E. (1999). Nomenclature for new tetracycline resistance determinants. Antimicrob. Agents Chemother. 43, 1523-1524.
89. Levy,S. B.,McMurry,L. M.,and Roberts, M. C. (2005). Tet protein hybrids. Antimicrob. Agents Chemother. 49, 3099.
90. Magnet, S., and Blanchard, J. S. (2005). Molecular insights into aminoglycoside action and resistance. Chem. Rev. 105, 477-497.
91. Magnet, S., Courvalin, P., and Lambert, T. (2001). Resistance-nodulationcell division type effux pump involved in aminoglycoside resistance in Acinetobacter baumannii strain BM4454. Antimicrob. Agents Chemother. 45, 3375-3380.
92. Maiden, M. C. J. (1998). Horizontal genetic exchange, evolution, and spread of antibiotic resistance in bacteria. Clin. Infect. Dis. 27, S12S20.
93. Makarova, K. S., Haft, D. H., Barrangou, R., Brouns, S. J., Charpentier, E., Horvath, P., Moineau, S., Mojica, F. J., Wolf, Y. I., Yakunin, A. F., van der Oost, J., and Koonin, E. V. (2011). Evolution and classification of the CRISPR-Cas systems. Nat. Rev. Microbiol. 9, 467-477.
94. MARAN. (2005). Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2005. Lelystad: CIDC-Lelystad. Available at: www.cidc-lelystad.nl.
95. MARAN. (2007). Monitoring of Antimicrobial Resistance and Antibiotic Usage in Animals in the Netherlands in 2006/2007. Lelystad: CVI-Lelystad. Available at: www.cvi.wur.nl.
96. Marshall, W. F., Vink, A., Orenstein, R., Wilson, J. W., and Estes, L. L. (2006). "Infectious diseases," in Mayo Clinic Internal Medicine Review 2006-2007, eds T. M. Habermann, A. K. Ghosh, and D. J. Rhodes (New York, NY: Taylor & Francis Group), 589.
97. Martínez-Martínez, L., Cano, M. E., Rodríguez-Martínez, R. M., Calvo, J., and Pascual, A. (2008). Plasmidmediated quinolone resistance. Expert Rev. Anti Infect. Ther. 6, 685-711.
98. Martínez-Martínez, L., Pascual, A., and Jacoby, G. A. (1998). Quinolone resistance from a transferable plasmid. Lancet 351, 797-799.
99. Mazel, D. (2006). Integrons: agents of bacterial evolution. Nat. Rev. Microbiol. 4, 608-620.
100. McCormick, M. H., Stark, W. M., Pittenger, G. E., Pittenger, R. C., and McGuire,J. M. (1956).Vancomycin a new antibiotic. I. Chemical and biological properties. Antibiot. Annu. 1955-1956, 606-611.
101. McDermott, P. F., Walker, R. D., and White, D. G. (2003). Antimicrobials: modes of action and mechanisms of resistance. Int. J. Toxicol. 22, 135-143.
102. McGuire, J. M., Bunch, R. L., Anderson, R. C., Boaz, H. E., Flynn, E. H., Powell, H. M., and Smith, J. W. (1952). Ìlotycin a new antibiotic. Antibiot. Chemother. 2, 281-283.
103. McMahon, S. A., Roberts, G. A., Johnson, K. A., Cooper, L. P., Liu, H., White, J. H., Carter, L. G., Sanghvi, B., Oke, M., Walkinshaw, M. D., Blakely, G. W., Naismith, J. H., and Dryden, D. T. F. (2009). Extensive DNA mimicry by the ArdA antirestriction protein and its role in the spread of antibiotic resistance. Nucleic Acids Res. 37, 4887-4897.
104. Meinhart, F., Schaffrath, R., and Larsen, M. (1997). Microbial linear plasmids. Appl. Microbiol. Biotechnol. 47, 329-336.
105. Moon, K., Shoemaker, N. B., Gardner, J. F., and Salyers, A. A. (2005). Regulation of excision genes of the Bacteroides conjugative transposon CTnDOT. J. Bacteriol. 187, 5732-5741.
106. Moore, R. A., DeShazer, D., Reckseidler, S., Weissman, A., and Woods,D. E. (1999). Effux-mediated aminoglycoside and macrolide resistance in Burkholderia pseudomallei. Antimicrob. Agents Chemother. 43, 465-470.
107. Murray, I. A., and Shaw, W. V. (1997). O-Acetyl-transferases for chloramphenicol and other natural products. Antimicrob. Agents Chemother. 41, 1-6.
108. Nair, J., Rouse, D. A., Bai, G.-H., and Morris, S. L. (1993). The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis. Mol. Microbiol. 10, 521-527.
109. NethMap. (2008). Consumption of Antimicrobial Agents and Antimicrobial Resistance Among Medically Important Bacteria in the Netherlands. Bilthoven: RIVM. Available at: www.swab.nl.
110. Neu, H. C. (1992). The crisis in antibiotic resistance. Science 257, 1064-1073.
111. Ochman, H., Lawrence, J. G., and Groisman, E. A. (2000). Lateral gene transfer and the nature of bacterial innovation. Nature 405, 299-304.
112. Oliva, B., and Chopra, I. (1992). Tet determinants provide poor protection against some tetracyclines: further evidence for division of tetracyclines into two classes. Antimicrob. Agents Chemother. 36, 876-878.
113. Olson, A. B., Silverman, M., Boyd, D. A., McGeer, A., Willey, B. M., Pong-Porter, V., Daneman, N., and Mulvey, M. R. (2005). Identification of a progenitor of the CTXM-9 group of extended-spectrum βlactamases from Kluyvera georgiana isolated in Guyana. Antimicrob. Agents Chemother. 49, 2112-2115.
114. Palmer, K. L., Kos, V. N., and Gilmore, M. S. (2010). Horizontal gene transfer and the genomics of enterococcal antibiotic resistance. Curr. Opin. Microbiol. 13, 632-639.
115. Parenti, F., Beretta, G., Berti, M., and Arioli, V. (1978). Teichomycins, new antibiotics from Actinoplanes teichomyceticus Nov. Sp. I. Description of the producer strain, fermentation studies and biological properties. J. Antibiot. 31, 276-283.
116. Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D., and Hooper, D. C. (2006). Prevalence in the United States of aac(6′)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob. Agents Chemother. 50, 3953-3955.
117. Partridge, S. R., and Hall, R. M. (2005). Correctly identifying the streptothricin resistance gene cassette. J. Clin. Microbiol. 43, 4298-4300.
118. Partridge, S. R., Tsafnat, G., Coiera, E., and Iredell, J. R. (2009). Gene cassettes and cassette arrays in mobile resistance integrons. FEMS Microbiol. Rev. 33, 757-784.
119. Paterson, D. L., and Bonomo, R. A. (2005). Extended-spectrum βLactamases: a clinical update. Clin. Microbiol. Rev. 18, 657-686.
120. Périchon, B., Courvalin, P., and Galimand, M. (2007). Transferable resistance to aminoglycosides by methylation of G1405 in 16S rRNA and to hydrophilic fluoroquinolones by QepA-mediated efflux in Escherichia coli. Antimicrob. Agents Chemother. 51, 2464-2469.
121. Perreten, V., and Boerlin, P. (2003). A new sulfonamide resistance gene (sul3) in Escherichia coli is widespread in the pig population of Switzerland. Antimicrob. Agents Chemother. 47, 1169-1172.
122. Petri, W. A. (2006). "Penicillins, cephalosporins, and other βlactam antibiotics," in Goodman & Gilmans, The Pharmacologic Basis of Therapeutics, edsL.L.Brunton,J. S. Lazo, and K. L. Parker (New York: The McGraw-Hill Companies), 1127-1154.
123. Poehlsgaard, J., and Douthwaite, S. (2005). The bacterial ribosome as a target for antibiotics. Nat. Rev. Microbiol. 3, 870-881.
124. Poirel, L., Naas, T., and Nordmann, P. (2010). Diversity, epidemiology, and genetics of class D β-lactamases. Antimicrob. Agents Chemother. 54, 24-38.
125. Poirel, L., Pitoud, J. D., and Nordmann, P. (2007). Carbapenemases: molecular diversity and clinical consequences. Food Microbiol. 2, 501-512
126. Queenan, A. M., and Bush, K. (2007). Carbapenemases: the versatile βlactamases. Clin. Microbiol. Rev. 20, 440-458.
127. Rådström, P., and Swedberg, G. (1988). RSF1010 and a conjugative plasmid contain sulII, one of two known genes for plasmid-borne sulfonamide resistance dihydropteroate synthase. Antimicrob. Agents Chemother. 32, 1684-1692.
128. Ramirez, M. S., and Tolmansky, M. E. (2010). Aminoglycoside modifying enzymes. Drug Resist. Updat. 13, 151-171.
129. Rasmussen, B., Noller, H. F., Daubresse, G., Oliva, B., Misulovin, Z., Rothstein, D. M., Ellestad, G. A., Gluzman, Y., Tally, F. P., and Chopra, I. (1991). Molecular basis of tetracycline action: identification of analogs whose primary target is not the bacterial ribosome. Antimicrob. Agents Chemother. 35, 2306-2311.
130. Rechia, G. D., and Hall, R. M. (1995). Gene cassettes: a new class of mobile element. Microbiology 141, 3015-3027.
131. Rechia, G. D., and Hall, R. M. (1997). Origins of the mobile gene cassettes found in integrons. Trends Microbiol. 5, 389-394.
132. Riley, M. A., and Wertz, J. E. (2002). Bacteriocins: evolution, ecology and application. Annu.Rev.Microbiol. 56, 117-137.
133. Roberts, A. P., Chandler, M., Courvalin, P., Guédon, G., Mullany, P., Pembroke, T., Rood, J. I., Jeffery Smith, C., Summers, A. O., Tsuda, M., and Berg, D. E. (2008). Revised nomenclature for transposable genetic elements. Plasmid 60, 167-173.
134. Roberts, A. P., and Mullany, P. (2009). A modular master on the move: the Tn916 family of mobile genetic elements. Trends Microbiol. 6, 251-258.
135. Roberts, M. C. (1996). Tetracycline resistance determinants: mechanisms of action, regulation of expression, genetic mobility, and distribution. FEMS Microbiol. Rev. 19, 1-24.
136. Roberts, M. C. (2002). Resistance to tetracycline, macrolidelincosamide-streptogramin, trimethoprim, and sulfonamide drug classes. Mol. Biotechnol. 20, 261-284.
137. Roberts, M. C. (2005). Update on acquired tetracycline resistance genes. FEMS Microbiol. Lett. 245, 195-203.
138. Roberts, M. C. (2008). Update on macrolide-lincosamidestreptogramin, ketolide, and oxazolidinone resistance genes. FEMS Microbiol. Lett. 282, 147-159.
139. Roberts, M. C., Sutcliffe, J., Courvalin, P., Jensen, L. B., Rood, J., and Seppala, H. (1999). Nomenclature for macrolide and macrolidelincosamide streptogramin B antibiotic resistance determinants. Antimicrob. Agents Chemother. 43, 2823-2830.
140. Robicsek, A., Jacoby, G. A., and Hooper, D. C. (2006a). The worldwide emergence of plasmid-mediated quinolone resistance. Lancet Infect. Dis. 6, 629-640.
141. Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Park, C. H., Bush, K., and Hooper, D. C. (2006b). Fluoroquinolonemodifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat. Med. 12, 83-88.
142. Roth, B., Falco, E. A., Hitchings, G. H., and Bushby, S. R. M. (1962). 5Benzyl-2,4-diaminopyrimidines as anti-bacterial agents. I. Synthesis and antibacterial activity in vitro. J. Med. Pharm. Chem. 5, 1103-1123.
143. Ruiz, J. (2003). Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection. J. Antimicrob. Chemother. 51, 1109-1117.
144. Saladin, M., Cao, V. T. B., Lambert, T., Donay, J.-L., Herrmann, J.-L., OuldHocine, Z., Verdet, C., Delisle, F., Philippon, A., and Arlet, G. (2002). Diversity of CTX-M β-lactamases and their promoter regions from Enterobacteriaceae isolated in three Parisian hospitals. FEMS Microbiol. Lett. 209, 161-168.
145. Schatz, A., and Waksman, S. A. (1944). Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. Proc. Soc. Exp. Biol. Med. 57, 244-248.
146. Schwarz, S., Kehrenberg, C., Doublet, B., and Cloeckaert, A. (2004). Molecular basis of bacterial resistance to chloramphenicol and florfenicol. FEMS Microbiol. Rev. 28, 519-542.
147. Shaw, K. J., Rather, P. N., Hare, R. S., and Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycosidemodifying enzymes. Microbiol. Rev. 57, 138-163.
148. Siegenthaler, W. E., Bonetti, A., and Luthy, R. (1986). Aminoglycoside antibiotics in infectious diseases. An overview. Am.J.Med.80, 2-14.
149. Siguier, P., Filée, J., and Chandler, M. (2006). Insertion sequences in prokaryotic genomes. Curr. Opin. Microbiol. 9, 526-531.
150. Sköld, O. (2000). Sulfonamides resistance: mechanisms and trends. Drug Resist. Updat. 3, 155-160.
151. Sköld, O. (2001). Resistance to trimethoprim and sulfonamides. Vet. Res. 32, 261-273.
152. Smillie, C., Garcillán-Barcia, M. P., Francia, M. V., Rocha, E. P. C., and de la Cruz, F. (2010). Mobility of plasmids. Microbiol. Mol. Biol. Rev. 74, 434-452.
153. Smith, H. O., Gwinn, M. L., and Salzberg, S. L. (1999). DNA uptake signal sequences in naturally transformable bacteria. Res. Microbiol. 150, 603-616.
154. Speer, B. S., Shoemaker, N. B., and Salyers, A. A. (1992). Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin. Microbiol. Rev. 5, 387-399.
155. Spratt, B. G. (1994). Resistance to antibiotics mediated by target alterations. Science 264, 388-393.
156. Stanton, T. B., Humphrey, S. B., Scott, K. P., and Flint, H. J. (2005). Hybrid tet genes and tet gene nomenclature: request for opinion. Antimicrob. Agents Chemother. 49, 1265-1266.
157. Stokes, H. W., and Hall, R. M. (1989). A novel family of potentially mobile DNA elements encoding site-specific gene-integration functions: integrons. Mol. Microbiol. 3, 1669-1683.
158. Strahilevitz, J., Jacoby, G. A., Hooper, D. C., and Robicsek, A. (2009). Plasmid-mediated quinolone resistance: a multifaceted threat. Clin. Microbiol. Rev. 22, 664-689.
159. Sun, H. I., Jeong, D. U., Lee, J. H., Wu, X., Park, K. S., Lee, J. J., Jeong, B. C., and Lee, S. H. (2010). A novel family (QnrAS) of plasmid-mediated quinolone resistance determinant. Int. J. Antimicrob. Agents 36, 573-580.
160. Sundström, L., Rådström, P., Swedberg, G., and Sköld, O. (1988). Sitespecific recombination promotes linkage between trimethoprimand sulfonamide-resistance genes. Sequence characterization of dhfrV and sulI and a recombination active locus of Tn21. Mol. Gen. Genet. 213, 191-201.
161. Swedberg, G., and Sköld, O. (1983). Plasmid-borne sulfonamide resistance determinants studied by restriction enzyme analysis. J. Bacteriol. 153, 1228-1237.
162. Taber, H. W., Mueller, J. P., Miller, P. F., and Arrow, A. S. (1987). Bacterial uptake of aminoglycoside antibiotics. Microbiol. Rev. 51, 439-457.
163. Torpdahl, M., Hammerum, A. M., Zachariasen, C., and Nielsen, E. M. (2009). Detection of qnr genes in Salmonella isolated from humans in Denmark. J. Antimicrob. Chemother. 63, 406-408.
164. Tschäpe, H., Tietze, E., Prager, R., Voigt, W., Wolter, E., and Seltmann, G. (1984). Plasmid-borne streptothricin resistance in gram-negative bacteria. Plasmid 12, 189-196.
165. Uttley, A. H. C., Collins, C. H., Naidoo, J., and George, R. C. (1988). Vancomycin-resistant enterococci. Lancet 331, 57-58.
166. Vakulenko, S. B., and Mobashery, S. (2003). Versatility of aminoglycosides and prospects for their future. Clin. Microbiol. Rev. 16, 430-450.
167. van Hoek, A. H. A. M., Mayrhofer, S., Domig, K. J., Flóres, A. B., Ammor, M. S., Mayo, B., and Aarts, H. J. M. (2008). Mosaic tetracycline resistance genes and their flanking regions in Bifidobacterium thermophilum and Lactobacillus johnsonii. Antimicrob. Agents Chemother. 52, 248-252.
168. Vester, B., and Douthwaite, S. (2001). Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45, 1-12.
169. Waksman, S. A., and Woodruff, H. B. (1942). Strepto-thricin, a new selective bacteriostatic and bactericidal agent, primarily active against Gram-negative bacteria. Proc. Soc. Exp. Biol. Med. 49, 207-210.
170. Watanabe, T. (1963). Infective heredity of multiple drug resistance in bacteria. Bacteriol. Rev. 27, 87-115.
171. Wei, Q., Jiang, X., Yang, Z., Chen, N., Chen, X., Li, G., and Lu, Y. (2009). dfrA27, a new integronassociated trimethoprim resistance gene from Escherichia coli. J. Antimicrob. Chemother. 63, 405-406.
172. Weisblum, B. (1995). Erythromycin resistance by ribosome modification. Antimicrob. Agents Chemother. 39, 577-585.
173. Weldhagen, G. F., Kim, B., Cho, C.-H., and Lee, S. H. (2006). Definitive nomenclature of GES/IBC-type extended-spectrum β-lactamases. J. Microbiol. Biotechnol. 16, 1837-1840.
174. Willi, K., Sandmeier, H., Kulik, E. M., and Meyer, J. (1997). Transduction of antibiotic resistance markers among Actinobacillus actinomycetemcomitans strains by temperate bacteriophages Aaφ23. Cell.Mol.LifeSci.53, 904-910.
175. Williams, J. D. (1987). "Classification of cephalosporins," in The Cephalosporins, ed. J. D. Williams (Auckland: ADIS Press Ltd.), 15-22.
176. Wolfson, J. S., and Hooper, D. C. (1989). Fluoroquinolone antimicrobial agents. Clin. Microbiol. Rev. 2, 378-424.
177. Woodford, N., Johnson, A. P., Morrison, D., and Speller, D. C. E. (1995). Currentperspectivesonglycopeptide resistance. Clin. Microbiol. Rev. 8, 585-615.
178. Wozniak, R. A. F., and Waldor, M. K. (2010). Integrative and conjugative elements: mosaic mobile genetic elements enabling dynamic lateral gene flow. Nat. Rev. Microbiol. 8, 552-563.
179. Wright, G. D. (1999). Aminoglycosidemodifying enzymes. Curr. Opin. Microbiol. 2, 499-503.
180. Wright, G. D. (2005). Bacterial resistance to antibiotics: enzymatic degradation and modification. Adv. Drug Deliv. Rev. 57, 1451-1470.
181. Wright, G. D., and Thompson, P. R. (1999). Aminoglycoside phosphotransferases: proteins, structure, and mechanism. Front. Biosci. 4, 9-21.
182. Wu, H. Y., Miller, G. H., Guzmán Blanco, M., Hare, R. S., and Shaw, K. J. (1997). Cloning and characterization of an aminoglycoside 6′-N -acetyltransferase gene from Citrobacter freundii which confers an altered resistance profile. Antimicrob. Agents Chemother. 41, 2439-2447.
183. Yamane, K., Wachino, J. I., Suzuki, S., Kimura, K., Shibata, N., Kato, H., Shibayama, K., Konda, T., and Arakawa, Y. (2007). New plasmid-mediated fluoroquinolone efflux pump, QepA, found in an Escherichia coli clinical isolate. Antimicrob. Agents Chemother. 51, 3354-3360.
184. Yao, R. C., and Crandall, L. W. (1994). "Glycopeptides: classification, occurrence and discovery," in Glycopeptide Atibiotics, ed. R. Nagarajan (New York, NY: Taylor & Francis Group), 1-28.
185. Zhanel, G., Walters, G. M., Noreddin, A., Vercaigne, L. M., Wierzbowski, A., Embil, J. M., Gin, A. S., Douthwaite, S., and Hoban, D. J. (2002). The ketolides: a critical review. Drugs 62, 1771-1804.